1. Home
  2. HTCR vs PULM Comparison

HTCR vs PULM Comparison

Compare HTCR & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heartcore Enterprises Inc.

HTCR

Heartcore Enterprises Inc.

N/A

Current Price

$0.33

Market Cap

11.7M

Sector

Technology

ML Signal

N/A

Logo Pulmatrix Inc.

PULM

Pulmatrix Inc.

N/A

Current Price

$2.30

Market Cap

13.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HTCR
PULM
Founded
2009
2003
Country
Japan
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7M
13.6M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
HTCR
PULM
Price
$0.33
$2.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
197.6K
28.7K
Earning Date
11-18-2025
10-16-2025
Dividend Yield
41.27%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$16,189,136.00
$3,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.52
$134.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$2.22
52 Week High
$3.38
$10.40

Technical Indicators

Market Signals
Indicator
HTCR
PULM
Relative Strength Index (RSI) 31.80 24.82
Support Level $0.31 $2.22
Resistance Level $0.38 $4.94
Average True Range (ATR) 0.04 0.42
MACD 0.00 -0.20
Stochastic Oscillator 46.22 4.02

Price Performance

Historical Comparison
HTCR
PULM

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

Share on Social Networks: